Eupraxia Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Eupraxia Pharmaceuticals prevailing Real Value cannot be determined due to lack of data. The current price of Eupraxia Pharmaceuticals is $0.0. Our model computes the value of Eupraxia Pharmaceuticals from reviewing the firm fundamentals such as Price To Book of 3.89 X, current valuation of 43.78 M, and Shares Owned By Insiders of 12.40 % as well as analyzing its technical indicators and probability of bankruptcy.
Eupraxia Pharmaceuticals Total Value Analysis
Eupraxia Pharmaceuticals is currently anticipated to have takeover price of 43.78 M with market capitalization of 78.89 M, debt of 9.26 M, and cash on hands of 35.46 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Eupraxia Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
43.78 M | 78.89 M | 9.26 M | 35.46 M |
Eupraxia Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Eupraxia is to check how much profit was generated for every dollar of assets it reports. Eupraxia Pharmaceuticals shows a negative utilization of assets of -0.33 percent, losing $0.003271 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Eupraxia Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Eupraxia Pharmaceuticals Ownership Allocation
Eupraxia Pharmaceuticals holds a total of 21.39 Million outstanding shares. Eupraxia Pharmaceuticals shows 12.4 percent of its outstanding shares held by insiders and 20.24 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Eupraxia Pharmaceuticals Profitability Analysis
Net Loss for the year was (22.99 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Eupraxia Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Eupraxia Pharmaceuticals and how it compares across the competition.
Eupraxia Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Eupraxia Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 14.2 M | |
| Retained Earnings | -74.2 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Eupraxia Pink Sheet
If you are still planning to invest in Eupraxia Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eupraxia Pharmaceuticals' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |